To understand more about the factors influencing the cleavage of immunoglobulin A1 (IgA1) by microbial IgA1 proteases, a recombinant human IgA2/IgA1 hybrid molecule was generated. In the hybrid, termed IgA2/A1 half hinge, a seven-amino-acid sequence corresponding to one half of the duplicated sequence making up the IgA1 hinge was incorporated into the equivalent site in IgA2. Insertion of the IgA1 half hinge into IgA2 did not affect antigen binding capacity or the functional activity of the hybrid molecule, as judged by its ability to bind to IgA Fc␣ receptors and trigger respiratory bursts in neutrophils. Although the IgA2/A1 hybrid contained only half of the IgA1 hinge, it was found to be cleaved by a variety of different bacterial IgA1 proteases, including representatives of those that cleave IgA1 in the different duplicated halves of the hinge, namely, those of Prevotella melaninogenica, Streptococcus pneumoniae, S. sanguis, Neisseria meningitidis types 1 and 2, N. gonorrhoeae types 1 and 2, and Haemophilus influenzae type 2. Thus, for these enzymes the recognition site for IgA1 cleavage is contained within half of the IgA1 hinge region; additional distal elements, if required, are provided by either an IgA1 or an IgA2 framework. In contrast, the IgA2/A1 hybrid appeared to be resistant to cleavage with S. oralis and some H. influenzae type 1 IgA1 proteases, suggesting these enzymes require additional determinants for efficient substrate recognition.
Secretory IgA (S-IgA) protects mucous membranes from attack by pathogenic microorganisms. It acts by neutralizing toxins, enzymes, and viruses, agglutinating bacteria, and preventing bacterial adhesion to mucous membranes by blocking receptors and, by virtue of its hydrophilic nature, causing repelling interactions with the mucosal epithelium (16, 18, 38, 40) .
The ability of S-IgA to carry out its defensive effector functions is dependent on its structural integrity. The physicochemical nature of S-IgA renders it resistant to most types of proteolytic attack (20) . However, a few pathogenic bacteria such as Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis, N. gonorrhoeae, and Prevotella melaninogenica, which cause infections at mucous membranes leading to diseases like pneumonia, meningitis, gonorrhea, and periodontitis, produce a variety of enzymes called IgA1 proteases (for reviews, see references 15, 26, and 35) . They are so named because they cleave only human IgA1 and not the IgA2 isotype. These enzymes may be important virulence factors because they are produced in vivo (3, 14) , convalescing patients from infections with these bacteria have neutralizing antibodies to the enzymes (5, 9, 11) , and the related but nonpathogenic species of these bacteria do not produce them (26) . Moreover, some may have a role in virulence by mechanisms additional to or distinct from that arising through IgA1 cleavage (19, 30) .
IgA2 is resistant to IgA1 proteases because it lacks a sequence of 16 amino acids which is present in the hinge region of IgA1 and which is the cleavage site for all IgA1 proteases. The sequence, which is rich in proline, threonine, and serine, is unusual in that it contains a repeat of two identical and contiguous sequences each of eight amino acids. Although the IgA1 proteases belong to widely different families, i.e., serine proteases, metallo proteases, and thiol proteases, they are all highly specific post-proline endopeptidases. The IgA1 proteases of the different bacteria always cleave at either Pro-Ser (type 1 enzymes) or Pro-Thr (type 2 enzymes) peptide bonds. However, they are extremely specific in that one enzyme of a given organism cleaves the specific peptide bond in only one of the duplicated eight amino acid sequences and not at the equivalent site in the other duplicated eight-amino-acid sequence ( Fig. 1) .
To understand more about the factors influencing the cleavage of IgA by microbial IgA1 proteases, a recombinant hybrid IgA molecule was constructed such that an amino acid sequence representing half of the duplicated hinge region of IgA1 was incorporated into the equivalent position in IgA2. The functional activity and sensitivity of the recombinant hybrid IgA2/A1 molecule to a variety of microbial IgA1 proteases were then determined.
MATERIALS AND METHODS
Primers. Primer A1H6 (5Ј GCGCGCGGATCCGGTCCAACCGCAGGCCC 3Ј) contained a BamHI site (italics) and annealed about 150 bp upstream of the CH1 exon of human IgA2m (1) . Primer A1H2 (5Ј AGATGGGGTAGGTGGAG TTGAGGGAACTGGAGTGG 3Ј) contained nucleotides complementary to nucleotides 675 to 688 of the coding strand for the CH1 region of human IgA2m (1) and (in italics) nucleotides complementary to nucleotides 667 to 687 of human IgA1, coding for half of the hinge region. Primer A1H3 (5Ј TCAACTCCACCT ACCCCATCTCCACCTCCCCCATG 3Ј) contained (in italics) the nucleotides coding for half the hinge region, i.e., nucleotides 667 to 687, of human IgA1, followed by nucleotides 689 to 702 of the coding strand for the CH2 region of human IgA2m(1). Primer A1H5 (5Ј CCACCTCTGACTTGA 3Ј) was comple-mentary to nucleotides 424 to 438 of the vector pSP73. All primers were made by the Oligonucleotide Synthesis Laboratory, Department of Biochemistry, University of Dundee.
Construction of IgA2/A1 half hinge expression vector. A plasmid bearing the gene for the CH1, CH2, and CH3 domains of the ␣ chain of human IgA2m(1) downstream of the mouse V NP gene (25) was cleaved with BamHI and XhoI, and the 1.4-kb fragment containing bp 1 to 737 of the ␣ 2 constant region was ligated into BamHI-XhoI-cut pSP73 (Promega, Southampton, United Kingdom). The resultant plasmid was used as a template for PCR overlap extension mutagenesis (13) using flanking primers A1H6 and A1H5 and internal primers A1H2 and A1H3. Thus, a fragment containing half of the hinge region of human IgA1 inserted between the CH1 and CH2 regions of human IgA2m(1) was engineered. Following digestion with BamHI and XhoI, the PCR product was ligated into the BamHI-XhoI-cut site of the original IgA2 expression vector, replacing the wildtype sequence in this region. Sequencing of the PCR-amplified region was performed by the dideoxy-chain termination method (7) .
Preparation of recombinant hybrid IgA2/A1 half hinge immunoglobulin. CHO-K1 cells were maintained as described previously (25) . CHO-K1 cells stably transfected previously with an appropriate mouse light (L) chain (25) were seeded in tissue culture-grade petri dishes and transfected with the IgA2/A1 hybrid expression vector by using calcium phosphate as described previously (25) . Positive transfectants were isolated by selection for the bacterial xanthineguanine phosphoribosyltransferase selectable marker by growth in medium supplemented with hypoxanthine and thymidine (HT supplement; Life Technologies, Paisley, United Kingdom), xanthine (0.25 mg/ml), and mycophenolic acid (10 g/ml). Several resistant colonies were picked, and cell lines producing the highest yields of IgA were identified by an enzyme-linked immunosorbent assay measuring binding to the antigen NIP (3-nitro-4-hydroxy-5-iodophenylacetate) as described previously (25) before expansion into large cultures. Recombinant antibodies were purified from supernatants of CHO-K1 transfectants by affinity chromatography on NIP-Sepharose as described previously (25) . The purified antibodies were supplemented with 0.04% sodium azide and stored in small aliquots at Ϫ20°C.
Recombinant IgA1 and IgA2. The antibodies were prepared in similar ways from previously described stable CHO-K1 transfectants (25) .
Rosette assays. Human erythrocytes were derivatized by incubation in isotonic borate buffer (pH 8.5) containing NIP-caproate-O-succinimide (100 g/ml; Genosys, Cambridge, United Kingdom) for 1 h at room temperature. The cells were then washed three times with phosphate-buffered saline (PBS) before and after fixation for 30 min with 3% glutaraldehyde prior to sensitization with essentially saturating amounts (Ͼ250 g/ml) of wild-type IgA1 or IgA2 or IgA2/A1 half hinge, making use of their specificity for the hapten NIP, as described previously (39) . Coating levels for each antibody were found to be equivalent by reactivity with goat anti-human IgA-fluorescein isothiocyanate conjugate (Caltag; Bradsure Biologicals, Loughborough, United Kingdom) as assessed by flow cytometry. Neutrophils were isolated as previously described (27) from heparinized blood taken from healthy volunteers. Rosetting of sensitized erythrocytes to neutrophils was performed in V-bottomed microtiter plates as described previously (39) . After addition of acridine orange solution (6 g/ml, final concentration) to stain nucleated cells, the cells were resuspended and examined by UV microscopy for rosetting. A rosette was defined as a fluorescent neutrophil with three or more erythrocytes attached.
Chemiluminescence assay of respiratory bursts. Wells of a chemiluminescence microtiter plate (Dynatech, Billinghurst, Sussex, United Kingdom) were coated with 150 l of 10 g of NIP-BSA/ml in coating buffer (0.1 M sodium carbonate buffer [pH 9.6]) and incubated overnight at 4°C. After three washes with PBS, 150 l of diluted antibody (50 g/ml) was added in triplicate to the wells and left overnight at 4°C. After three washes in PBS, 100 l of luminol (67 g/ml in Hanks' balanced salt solution [ were pure; the others were partially purified and either concentrated from liquid culture supernatants or prepared as previously described (34) from the bacteria grown on dialysis tubing covering appropriate culture media, blood agar, heated blood agar, or modified New York City agar for 3 days at 37°C in 5% CO 2 . The enzyme preparations were stored at Ϫ20°C.
Digestion of recombinant IgA preparations with microbial IgA1 proteases and immunoblotting.
Initial preliminary experiments determined the appropriate volumes of protease and antibody to use to permit assessment of cleavage by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Such volumes of recombinant IgA1 or IgA2 or hybrid IgA2/A1 and the microbial IgA1 protease preparations were added to PBS (pH 7.2) containing 0.1% sodium azide to give a total volume of 20 l. In the case of P. melaninogenica protease, the buffer used was 0.1 M sodium phosphate (pH 5.5) containing 0.1 mM EDTA and 0.1 mM dithiothreitol. The reaction mixtures were incubated at 37°C for 72 h prior to analysis on SDS-10% polyacrylamide gels under reducing and nonreducing conditions. The proteins were then transferred to nitrocellulose membranes, which were then blocked by agitation for 30 min in 5% nonfat dried milk powder in PBS. After thorough washing in PBS, the membranes were immersed in horseradish peroxidase-labeled antibody, either sheep anti-human IgA Fc antibody (Sigma) or goat anti-human IgA (Kirkegaard & Perry Laboratories, Gaithersburg, Md.) or sheep anti-mouse L-chain antibody (Nordic Immunological Laboratories, Tilburg, The Netherlands) diluted 1:1,000 in PBS containing 0.1% Tween 20 (PBST) and agitated for 2 h at room temperature.
When examination was to be made for binding of biotinylated lectins, the nitrocellulose membranes were blocked by immersion in 1% BSA in PBST and agitation for 30 min. After incubation with the biotinylated lectin (Vector Laboratories, Peterborough, United Kingdom) for 1 to 2 h at room temperature and thorough washing in PBS, the membranes were incubated with 1 g of streptavidin-labeled horseradish peroxidase per ml in PBS for 30 min at room temperature.
In all instances, after thorough washing in PBS, the membranes were developed in 10 ml of 50 mM Tris-HCl (pH 7.6) buffer containing 0.3 mg of nickel chloride per ml, 10 mg of diaminobenzidine, and 60 l of 30% hydrogen peroxide.
RESULTS
Expression of IgA2/A1 half hinge in CHO-K1 cells. DNA sequence analysis of the IgA2/A1 half hinge expression vector confirmed that nucleotides 667 to 687 of ␣ 1 had been correctly incorporated between nucleotides 688 and 689 of ␣ 2 and that no misincorporations had occurred during PCR amplification.
Analysis of the IgA2/A1 half hinge antibody expressed in CHO-K1 cells showed that in the reduced form, the hybrid ␣ 2 /␣ 1 chain appeared as two glycoprotein bands of 68 and 63 kDa (Fig. 2) . These differed only in the extent of N-glycosylation, for after incubation with recombinant peptide-N-glycosidase F (Glyko, Upper Heyford, Nr. Bicester, United King- dom), which removes N-linked oligosaccharides, the hybrid ␣ 2 /␣ 1 chain no longer bound biotinylated concanavalin A and appeared as a single band of ca. 58 kDa (Fig. 2) . This size was similar to or possibly a little smaller than that of the deglycosylated wild-type ␣ 1 chain and a little bigger than that of the deglycosylated wild-type ␣ 2 chain as expected. Analysis of the hybrid IgA2/A1 in its nonreduced form by SDS-PAGE and immunoblotting revealed a major band of about 50 kDa reactive with anti-L-chain antibody and another of about 120 kDa reactive with anti-IgA ␣-chain antibody (Fig. 3) . Equivalent bands were observed with the wild-type IgA2m(1) and have been identified earlier as L-chain dimers and heavy (H)-chain dimers, respectively (25) . These dimers arise under nonreducing conditions because in the majority of IgA2m(1) molecules, in contrast to most other antibody molecules, disulfide bonds do not form between H and L chains. Instead, the L chains are disulfide bonded to each other (24) . The recombinant hybrid IgA2/A1 antibody appeared to share this bonding pattern, as was expected, given that it retained the elements of IgA2m(1) involved in interchain disulfide bridge formation. In wild-type IgA1 the H chains are disulfide bonded to each other and to the L chains, resulting, under nonreducing conditions, in a band of about 170 kDa which was reactive with both anti-Hchain and anti-L-chain reagents (Fig. 3) . A 170-kDa band containing both H and L chains was also evident in wild-type IgA2m(1) and to a lesser extent in IgA2/A1 half hinge (Fig. 3) . It is now appreciated that disulfide bonds can be formed between H and L chains in IgA2m(1) but with low frequency (8) , and this obviously also applies to the IgA2/A1 half hinge molecule.
The hybrid IgA2/A1 half hinge molecule was examined for the presence of O-glycosylated amino acids in the half-hinge region by determining its ability to bind the biotinylated lectin jacalin (from Artocarpus integrifolia). The results showed that like the wild-type IgA1, the hybrid IgA2/A1 half hinge molecule bound jacalin and thus contained O-glycosylated amino acids, whereas, as expected, the wild-type IgA2 molecule did not (Fig. 4) .
Ability of IgA2/A1 half hinge to bind and trigger Fc␣R. Analysis of the functional activity of the hybrid IgA2/A1 molecule showed it to be comparable to wild-type IgA1 and IgA2 in the ability to mediate rosette formation between NIP-coated erythrocytes and neutrophils through interaction with Fc␣ receptors (Fc␣R) ( Table 1) . Moreover, chemiluminescence assays revealed that the hybrid IgA2/A1 half hinge molecule bound efficiently to Fc␣R on neutrophils and promoted a respiratory burst (Fig. 5) . The respiratory bursts stimulated by the recombinant IgA1 and IgA2 mirror closely those reported earlier for serum-derived IgA1 and IgA2 (37) . The IgA2/A1 hybrid produced a respiratory burst comparable to that produced by the wild-type antibodies. Thus, the functional activity of the recombinant IgA2/A1 hybrid in these respects was very similar to that of wild-type IgA1 and IgA2. This finding is in keeping with the localization of the Fc␣R binding site on IgA to the region between the CH2 and CH3 domains of the Fc, some distance from the hinge (6, 28) .
Activities of different microbial IgA1 proteases on IgA2/A1 half hinge. The susceptibility of IgA2/A1 half hinge to a number of bacterial IgA1 proteases was examined. All of the en- Examination of the sensitivity of wild-type IgA1 and IgA2/A1 half hinge to the different streptococcal IgA1 proteases showed that although all of the enzymes were active and cleaved IgA1 to Fab and Fc fragments, the IgA2/A1 half hinge hybrid was sensitive only to those of S. pneumoniae and S. sanguis and resistant to that of S. oralis (Fig. 6) . Interpretation of the relative sizes of the cleavage products requires careful consideration of both the N-linked sugar moieties in the Fc of IgA1 (two per Fc H chain) and of IgA2/A1 (three per Fc H chain) and also the differing presence of contaminating glycosidase activity in the protease preparations. Although the proteases from S. pneumoniae and S. oralis cleaved the wild-type IgA1 to produce IgA1 fragments of the same sizes of ca. 28 and 27 kDa (Fig. 6, lanes 2 and 4) , the fragments generated by cleavage with S. sanguis protease (Fig. 6, lane 3) were marginally larger. Moreover, the size of the fragments generated by cleavage of the IgA2/A1 half hinge by the protease from S. pneumoniae (Fig. 6, lane 6 ) differed in size from those resulting from cleavage with S. sanguis protease (Fig. 6, lane 7) . The reason for this is thought to be a consequence of the S. pneumoniae (and S. oralis) protease preparations, but not that of S. sanguis, also having glycosidase activity as has been observed previously (33) . Thus, when the S. pneumoniae cleavage of IgA2/A1 half hinge was repeated in the presence of 25 mM EDTA to inhibit the S. pneumoniae IgA1 metalloproteinase activity, although there was no proteolytic cleavage of IgA2/ A1, the hybrid antibody was nevertheless deglycosylated to a protein of ca. 56 kDa (Fig. 7) . The difference in the sizes of the IgA fragments produced by the different enzymes is more marked for the IgA2/A1 half hinge than for the wild-type IgA1, presumably because of the loss of three sugar moieties in the former, compared with just two in the latter.
The action on wild-type IgA1 and the IgA2/A1 half hinge of the IgA1 proteases of S. pneumoniae, N. meningitidis type 2, and N. gonorrhoeae type 1, which cleave at different sites in the full hinge of IgA1 (Fig. 1) , is shown in Fig. 8 . All of these enzymes which cleaved IgA1 were also found to be able to cleave the hybrid IgA2/A1. The lower molecular weight of the fragments produced by the S. pneumoniae protease than of the fragments produced by the different Neisseria proteases is presumably due to the additional activity of glycosidases in the S. pneumoniae preparation (see above). The hybrid IgA2/A1 was also found to be sensitive to the type 1 protease of N. meningitidis and the type 2 protease of N. gonorrhoeae (results not shown), which cleave the same peptide bonds in IgA1 as N. gonorrhoeae type 1 protease and N. meningitidis type 2 protease, respectively. Moreover, the hybrid IgA2/A1 was also sensitive to P. melaninogenica protease, which cleaves IgA1 at the opposite end of the full hinge in IgA1 (Fig. 1) to that cleaved by the type 1 protease of N. meningitidis (Fig. 9) .
Investigations into the sensitivity of IgA2/A1 half hinge to type 1 and type 2 IgA1 proteases of H. influenzae showed that although the hybrid immunoglobulin was cleaved by the type 2 enzyme, it was much more resistant to the type 1 enzyme of strain HK368. Further investigation with type 1 enzymes from seven different H. influenzae strains of biotypes I (R27), II (R12, R14, and R16), III (R20), IV (R11), and VII (R25) showed that the IgA2/A1 hybrid was sensitive to four of these type 1 proteases but resistant to three of them (Fig. 10) .
DISCUSSION
Microbial IgA1 proteases are extremely specific. Excepting peptide bonds present in precursors of the enzymes which are cleaved in their processing, LAMP1 (the major integral membrane protein of lysosomes) (19) , and some outer membrane proteins of N. gonorrhoeae (36) , the only known substrate of IgA1 protease is IgA1 of humans, gorillas, chimpanzees, and orangutans (32) . Little is known about what determines the specificity of IgA1 proteases. The fact that they cleave human IgA1 at specific sites in only one of the two available duplicated sites in the hinge suggests that the two duplicated half hinges have different conformations or that the enzymes recognize additional elements distant from the cleavage site.
In an attempt to gain further information about the requirements of IgA for sensitivity to IgA1 proteases and the determinants of specificity of IgA1 proteases, seven amino acids representing a half hinge region of human IgA1 were introduced into protease-resistant human IgA2 to create an artificial half hinge. The hybrid IgA2/A1 molecule was found to have an arrangement similar to that of IgA2m(1) with regard to the bonding of its H and L chains and was deemed to be functionally active in that it could form rosettes and bind efficiently to Fc␣R on neutrophils and trigger a respiratory burst. However, it now possessed the O-glycosylated amino acids of half the hinge of IgA1 and showed sensitivity to several diverse IgA1 proteases.
Determination of the exact site of cleavage by the enzymes in the IgA2/A1 hybrid was felt beyond the scope of this study because of the work involved in analyzing the cleavage products generated by so many different enzymes. However, because of the known extreme specificity of bacterial IgA1 proteases, it is not unreasonable to assume that the cleavage site for each enzyme in the IgA2/A1 half hinge hybrid is identical to its natural cleavage site in one of the duplicated half hinge regions of the wild-type IgA1 molecule, although conclusive proof requires amino acid sequence analysis of the cleavage products.
The IgA1 proteases active on the IgA2/A1 half hinge hybrid included representatives of those which cleave at specific sites in both of the duplicated half hinges of IgA1, namely, the IgA1 proteases of S. pneumoniae, S. sanguis, H. influenzae 2, N. gonorrhoeae 1 and 2, N. meningitidis 1 and 2, and P. melaninogenica (Fig. 1) . Thus, for these enzymes it would appear that although they cleave IgA1 naturally at a specific peptide bond in only one of the duplicated half hinge areas (the preferred cleavage site), if the specific peptide is represented only once as in the IgA2/A1 half hinge hybrid, these enzymes will still cleave IgA, thereby overriding the determinants of site selectivity. The results also indicate that for these enzymes the recognition site for IgA cleavage is contained in a half hinge region or that if additional more distal elements are required, the framework of IgA2 substitutes reasonably adequately for that of IgA1. These results support the work of Pohlner et al. (29) and that of others (1) who have suggested that the consensus target sequence for serine-type IgA1 proteases of Neisseria and Haemophilus is either P-P2S/T-P or P-X-P2S/T/ ST-P, where X is any amino acid, S/T is serine or threonine, and S/T/ST is serine or threonine or both. These sequences are provided in the IgA2/A1 half hinge molecule. A proline as the amino acid N-terminal to the cleaved peptide bond is a requirement for Haemophilus and Neisseria IgA1 proteases (1) . Proline residues introduce bends into polypeptide chains, and these may expose sites for essential protein-protein interactions.
It was not very surprising, therefore, to find that the IgA2/A1 hybrid was sensitive to most of the IgA1 proteases of Haemophilus and Neiserria spp., for these are serine-type proteases that can be inhibited by short peptides. Bachovchin et al. (1) showed that tri-and tetrapeptide prolyl boronic acid analogues could block the active site of the serine-type IgA1 proteases of Haemophilus and Neisseria (but not that of the metalloproteinase IgA1 protease of S. sanguis) and that synthetic short peptides were cleaved more slowly than the IgA1 hinge. This suggests that maximum efficiency in cleavage occurs only when the substrate has the correct length and conformation. In support of this conclusion, it was repeatedly found that the cleavage of the IgA2/A1 hybrid by IgA1 proteases from some organisms was less complete than that of wild-type IgA1 after incubation for similar periods. This suggests not only that cleavage of IgA requires the presence of a cleavable peptide bond at the correct location but also that other parts of the digested with type 2 protease of H. influenzae 110023H and R4 (lanes 2 and 7, respectively) and type 1 protease of H. influenzae R11, R12, R14, R16, R20, R25, and R27 (lanes 3 to 6 and 8 to 10, respectively) and probed with anti-human IgA-peroxidase conjugate. The proteases of all strains were active on wild-type IgA1, but although the type 2 enzyme of H. influenzae cleaved the hybrid IgA2/A1 immunoglobulin, it was resistant to the type 1 protease of some H. influenzae strains (R12, R25, and R27). molecule influence its sensitivity to IgA protease cleavage. Although in this study substrate-enzyme reactions were usually incubated for 72 h, this was done in order not to miss substrate cleavage by any slow-acting IgA1 protease on the IgA2/A1 hybrid. In fact, all IgA1 proteases that hydrolyzed the hybrid demonstrated cleavage within 16 h. A more detailed comparison of the kinetics of IgA1 protease cleavage of the IgA2/A1 half hinge with that of wild-type IgA1 is to be the subject of a separate investigation.
The reason for the resistance of the IgA2/A1 hybrid to some H. influenzae type 1 proteases is not clear. It is known for organisms like H. influenzae (and N. meningitidis), which produce type 1 and type 2 proteases which cleave at different sites within one of the duplicated half hinge sites, that the site of cleavage is determined by a region near the amino-terminal end of each protease known as the cleavage site determinant (CSD) (12) . Comparisons between the CSDs of different organisms have shown that the CSD length varies with the enzyme and is proportional to the distance between the interchain disulfide bridge at the top of the CH2 domains prior to the hinge, i.e., Cys 241, and the specific peptide bond cleaved by the enzyme (21) . It has been suggested that the CSD acts as a spacer between the catalytic site and the substrate recognition site. Consistent with this is the finding that cleavage appears to be dependent on hinge structural features C-terminal to the susceptible peptide bond because sequential incubation with different IgA1 proteases resulted in cleavage of Fc but not Fab fragments (21) . As the CSD of H. influenzae type 1 protease is bigger than that of all of the other enzymes (21) and there is known to be much variation in the CSDs of type 1 proteases of H. influenzae, it is possible that for some H. influenzae type 1 proteases a single half hinge site is too small to accommodate such a large CSD spacer and the enzyme is directed to act at a site outside the half hinge where a Pro-Ser bond is not present for cleavage. Alternatively, because the IgA1 proteases of H. influenzae are the most antigenically diverse, more than 30 antigenic types having been described on the basis of antibody neutralization tests (17, 22) , it may be that some are unable to cleave the IgA2/A1 hybrid because of steric hindrance due to their increased bulk and the closer approach of the Fc and Fab arms.
The inability of the protease of S. oralis alone among the streptococcal IgA1 proteases to cleave the IgA2/A1 hybrid is difficult to understand and explain, for all are metalloproteinases, the cleavage site on IgA1 is the same for all, and their amino acid sequences are highly homogeneous (31) . Moreover, unlike the situation with H. influenzae type 1 proteases, the proteases of S. oralis are all of one antigenic type (33) . However, the iga protease gene in S. oralis contains elements displaying subtle differences from those of S. sanguis and S. pneumoniae which may contribute to a particular cleavage site specificity. It is also possible that the S. oralis protease requires structures outside the half hinge in the hybrid antibody for which IgA2 elements are not an acceptable alternative to IgA1 elements for substrate recognition.
The susceptibility of IgA1 to IgA1 proteases can be influenced by its state of glycosylation (33) , and it is possible that the carbohydrates in the hinge region contribute to the specificity of IgA1 proteases. The IgA1 hinge region contains several potential sites for O-linked glycosylation (2, 33) . Classically, in studies of IgA1 myelomas, these have been considered to be the five serine residues, four of which have galactosyl-␤1-3-N-acetylgalactosamine groups (and possibly sialic acid 33) whereas Ser 224 has N-acetylgalactosamine (10) . More recently, however, analysis of IgA1 from serum indicates that the sugars are O-linked via both serine and threonine residues asymmetrically distributed between the two duplicated halves of the hinge (22) . Thus, it could be argued that the two duplicated half hinges in wild-type IgA1 are distinguishable on the basis of differences in glycosylation.
The half hinge region of the IgA2/A1 hybrid is believed to be O-glycosylated, for it was found to bind the biotinylated lectin jacalin, which is specific for the O-linked sugars restricted to the hinge of IgA1. Although the exact state of glycosylation of the half hinge region is not known, it can at best presumably resemble only one of the half hinges of IgA. Thus, it is unlikely that the O-linked sugars act as determinants of specificity and direct the protease specifically to one of the duplicated half hinge regions in IgA1 because representatives of proteases acting in each of these different regions in IgA1 were all able to cleave IgA2/A1 half hinge. If the half hinge in the IgA2/A1 hybrid is underglycosylated or glycosylated incorrectly in other ways, it is unlikely that this is the reason for the resistance of the molecule to the S. oralis and some H. influenzae type 1 proteases because we have observed (M. R. Batten, B. W. Senior, M. Kilian, and J. M. Woof, unpublished data) that when O-linked glycosylation of the IgA1 hinge region was perturbed through substitution of its serine residues with alanine and that of threonine 225 with valine, the modified IgA1 molecules nevertheless remained sensitive to virtually all types of IgA1 proteases, including those of S. oralis and H. influenzae type 1.
A molecular model for human IgA1 based on small-angle X-ray and neutron-scattering analysis has recently been generated (4). The average conformation of the antibody is predicted to be T shaped, with the Fab arms widely separated. The hinge peptides are suggested to adopt extended, exposed structures, presumably readily accessible to IgA1 proteases. In the IgA2/A1 hybrid, a similar structural arrangement may be present but with the Fab arms held much closer to the Fc portion. A maintained exposure of the shortened hinge might then explain the continued access, recognition, and thus sensitivity of the molecule to most of the IgA1 proteases, whereas the closer proximity of the Fab and Fc regions may for some IgA1 proteases present an unfavorable arrangement for access or substrate recognition or both.
In summary, this study has shown that through the insertion into protease-resistant IgA2 of seven amino acids representing half the hinge region of IgA1, a hybrid IgA2/A1 molecule that was functionally active and sensitive to many different bacterial IgA1 proteases was formed.
